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A B S T R A C T
Diagnosis of Wegener’s granulomatosis at the early stage is difficult because of the nonspecific symptoms which
mimic other disorders. The aim of this paper is to describe clinical and radiological features of Wegener’s granulo-
matosis (WG) in a Serbian population at initial presentation. A retrospective review of 37 patient's case records was car-
ried out. All those patients were diagnosed with WG and they attended the Institute for lung diseases in Belgrade over
the period of 15 years. There were 20 males and 17 females, ranging in age from 18 to 73 years (mean age 46.2 years).
The mean period from the onset of the first symptoms to diagnosis of WG was 4.59±6.15 months. The criteria of Ameri-
can College of Rheumatology were fulfilled in all patients. Twenty-five of 37 patients had systemic, generalized form of
WG and while 12 of them had a limited involvement of upper and lower respiratory system. The frequency of different
system involvement was: upper respiratory tract 64.8%, lower respiratory tract 100%, kidneys 67.5%, musculoskeletal
system 40.5%, skin 27.2%, eyes 8.1%, and nervous system two patients. ANCA (antineutrophil cytoplasmic antibodies)
test was positive in 32((86.5%) patients, and negative in 5(13.5%). All patients were ANA negative. Histological evidence
of granulomatous vasculitis was obtained in 34(91.9%), whereas in three patients the diagnosis was based on clinical
manifestations and positive c-ANCA test. There are minor variations in our data when compared with those reported in
literature.
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Introduction
Wegener’s granulomatosis is a distinct syndrome cha-
racterized by necrotizing granulomatous vasculitis that
affects small and medium blood vessels of the involved
organs. The cause of disease is not known. It belongs to a
group of primary systemic vasculitides of unknown etiol-
ogy that are associated with antineutrophil cytoplasmic
antibodies (ANCA)1–4. The most frequently affected or-
gans are upper respiratory tract, lungs and kidneys. The
spectrum of diseases extends from a limited or localized
involvement to a florid, extensive, and fatal multisyste-
mic illness1–3. A limited formmay be presented by pulmo-
nary lesions without kidney lesions. This variant has a
good prognosis. The nonspecific symptoms of the disease
like fever, arthralgia, skin lesions can mimic other dis-
eases and cause delay in the diagnosis1,2. In addition to
clinical and radiographic findings, the diagnosis of WG is
confirmed by antineutrophil cytoplasmic antibodies as
serological marker and biopsy. Detection of c-ANCA is a
useful test in diagnosing WG 4. With the introduction of
ANCA as a serological marker, WG is diagnosed at an
earlier stage and with a greater degree of certainty. The
test however may be negative in localized form of di-
sease4,5.
The purpose of this report is to show a group of 37 pa-
tients with Wegener’s granulomatosis (WG) from our In-
stitute, to analyze the clinical and radiological manifesta-
tions and compare our results with other published series.
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Patients and Methods
The group of patients that were hospitalized at Insti-
tute for chest diseases and TB due to respiratory symp-
toms and non-resolving chest x-ray opacities in the pe-
riod of 15 years was included in this study. Patients
underwent an interdisciplinary clinical examinations to
asses the extent of disease. The clinical examination in-
cluded ear, nose and throat, respiratory and general
physical examination. The radiological examination in-
cluded plain chest x-ray and computerized tomography
(CT) of thorax and paranasal sinuses. In one patient with
high grade subglottic stenosis, magnetic resonance imag-
ing (MRI) of the neck was done. Ultrasonography of ab-
domen and kidney were obtained in all patients. Lung
function test and bronchoscopy were done in two thirds
of patients. The laboratory data recorded were haemo-
globin concentration, complete blood cell count, ESR, se-
rum creatinine level, urine examination for red blood
cells, proteins and casts. The presence of c-ANCA and
p-ANCA was detected by using the indirect immuno-
fluorescence and ELISA method4. Tests for antinuclear
antibody were done in every patient. Presenting labora-
tory features and clinical signs at the time of diagnosis
were analyzed. The time span from onset of the first
symptoms related to Wegener’s granulomatosis to the di-
agnosis was also recorded. In order to confirm the diag-
nosis we used the criteria introduced in 1990 by The
American College of Rheumatology (ACR)6. The diagno-
sis was made by these criteria in conjunction with the
clinical symptoms, histopathology findings and blood
test results for serum c-ANCA and p-ANCA.
Results
Patient’s features
The group had 37 patients, with a majority of male
(54%). The mean age was 46.2 years, (range from 18 to
73 years of age). Mean period from the onset of first
symptoms to a diagnosis of Wegener’s granulomatosis
was 4.59±6.15 months (Table 1). In most patients diagno-
sis of WG was made within six months of the onset of
symptoms (Graph 1). Twenty-five (67.5%) patients had
constitutional symptoms like fever, malaise, weight loss.
Organ system involvement
Majority of patients initially sought medical care be-
cause of upper or lower airway symptoms (Table 2). Out
of 37 patients, 12 (32.5%) had limited WG with involve-
ment of only upper and lower respiratory tract. The clas-
sic triad of upper and lower respiratory tract and kidney
involvement at the time of diagnosis was seen in 25
(67.5%) patients. The frequency of different system in-
volvement at initial presentation is shown in Table 3.
Respiratory clinical features
Upper respiratory tract involvement was noted in 24
(64.8%) patients. This included nasal, sinus, ear and pha-
ryngeal symptoms (Graph 2). Inflammation of paranasal
sinuses was presented with chronic sinusitis. Three of
our patients suffered from nasal granulomatous inflam-
mation and two from crusting. All of them have had
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Graph 1. Duration of symptoms (in months).
TABLE 1






Number of patients 37 158 85
M:F 1:1.18 1:1 1.6:1
Age
Mean 46.2 41 43.6
Range 18–73 9–78 14–75
Duration of symptoms before diagnosis(months)
Mean 4.6 15 8.3
Range 0.5–36 0–120 0.5–120
*Wegener granulomatosis
TABLE 2
CLINICAL SYMPTOMS IN WEGENER’S GRANULOMATOSIS
Symptoms Our series Hoffman et al.(2) Fauci et al.(1)
Constitutional 25 (67.5%) 36 (23%) 29 (34%)
Cough 37 (100%) 30 (19%) 29 (34%)
Hemopthysis 34 (91.9%) 19 (12%) 15 (18%)
Dyspnea 18 (48.6%) NR 6 (7%)












Graph 2. Upper respiratory tract involvement.
bloody nasal discharge for several weeks. The symptoms
of ear involvement were earache, hearing loss and tin-
nitus. The main finding on examination was suppurative
otitis media. Ten (27.9%) patients had ulceration of oral
mucosa.
Lower respiratory system was involved in all patients
at initial presentation. Pulmonary symptoms included
cough in all patients, dyspnea and hemoptysis (Table 2).
Five patients (13.5%) had only lung involvement. Lung
function tests were done in 24 patients and showed re-
strictive defect related to space-occupying lesions in the
chest in 12 (50%) patients, air flow obstruction in six,
and mixed pattern of restriction and obstruction in three
patients. Normal lung function test was in three pa-
tients. In other patient these tests were unavailable.
Twenty-seven (73%) patients underwent bronchoscopy
which was abnormal in 22 (81%) cases. Pathologic endo-
bronchial finding consisted of inflammation in 19 cases,
isolated hemorrhage in two and compression of the bronch
by tumor mass in one case. Bronchial biopsies showed
mild nonspecific chronic inflammation in 9 cases and
granulomatous vasculitis in 10 cases. Lung involvement
was confirmed by open thoracotomy in five patients and
by lung biopsy in four cases.
Upper and lower airways imaging
Plain film and CT of paranasal sinuses revealed mu-
cosal thickening with opacifications in 19 patients and
air-fluid levels in three cases (Figure 1).
Pulmonary symptoms were associated with chest x-
-ray abnormalities in all of our patients at the time of
presentation (Table 4).
Radiographs or CT of the thorax showed bilateral
opacities in 62.1% and unilateral in 37.9%. In 20 (54%)
patients areas of consolidation were observed. These
opacities spared the apices and ranged from focal consoli-
dation in five cases to frank bilateral consolidation in 12
patients (Figure 2). Cavitations of the consolidations oc-
curred in 5 (25%) patients. Diffuse, bilateral, and low
density opacities occurred in three patients (Figure 3).
One patient with focal consolidation had accompanying
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TABLE 3








Number of patients 37 158 85
Organ involvement, No(%)
Upper respiratory tract 24 (64.8%) 115 (73%) 57 (67%)
Lung 37 (100%) 71 (45%) 60 (71%)
Kidney 25 (67.5%) 28 (18%) 9 (11%)
Joints 15 (40.5%) 50 (32%) 37 (44%)
Skin 10 (27%) 20 (13%) 11 (13%)
Eye 3 (8.1%) 24 (15%) 14 (16%)
Peripheral nervous system 2 (5.4%) 24 (15%) 1 (1.17%)
TABLE 4








Nodules and mass 2+3 (13.5%) 35 (22%) 5 (20 %)
Cavitation 12 (32.4%) NR 9 (36%)
Consolidation 19 (54.0%) 36 (23%) 7 (28%)
Pleural effusion 1 case with
consolidation
16 (10%) 0
Number of patients 37 158 25
Fig. 1. CT of sinuses shows mucosal thickening and air-fluid
level of the right maxillary sinus.
Fig. 2. Thoracic CT scan with soft tissue window demonstrates
ill-defined parenchimal consolidation bilateral, with a small ca-
vitation in the left lung.
pleural effusion. Nodules were present in 17 (45.9%) pa-
tients, five without cavities (Figure 4) and 12 (64.7%)
with cavities (Figure 5). They were bilateral in 10 (58.8 %)
patients. The number was from two to innumerable and
the size varied from 1.0 to 10 cm. Hilar and mediastinal
adenopathy was rare finding, just in one patient. One pa-
tient with massive bilateral opacities had associated high
grade subglottic tracheal stenosis (Figure 6).
Kidney involvement
Twenty-five of our patients had kidney disease. All of
them had hematuria and proteinuria at initial presenta-
tion. Blood biochemistry analysis revealed elevated levels
of serum urea and creatinine in 25 patients and azotemia
in 19 of those (67.5% and 76.0% respectively). Median se-
rum creatinine level was 414.8 mmol/L. Ultrasonography
of kidneys confirmed morphological changes in 17 (68.0%)
patients. Large echogenic kidneys on ultrasound without
specific Doppler abnormalities were most common find-
ing in our patient. Diagnosis of WG was confirmed in 8
patients by percutaneous renal biopsy.
Clinical features of the other organ involvement
Musculoskeletal symptoms were present in 15 (40.5%)
patients with arthralgia and myalgia. Skin disease mani-
festations occurred in 10 (27.02%) patients: four with
purpura, three with ulceration, maculae and nodules one
each and one with mastitis. In five patients skin biopsy
showed necrotizing vasculitis.
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Fig. 5. Chest CT scan with lung window demonstrates a large
cavitary mass with thick irregular borders in the right upper lo-
be, and the smaller one in the left lung.
Fig. 4. Chest CT sacn with lung window shows multiple nodules
in right lower lobe.
Fig.3. Chest CT scan with lung window demonstrates ground
glass opacities in both lungs with small nodules along with bron-
chovascular bundle.
Fig. 6. MRI of the neck in sagittal view shows high grade sub-
glottic stenosis.
Ocular abnormalities were seen in 3(8.1%) patients
with signs of scleritis, conjunctivits and retinal vas-
culitis. Nervous system was involved in two patients
manifesting with mononeuritis multiplex. There were no
patients in our series with central nervous system in-
volvement.
Laboratory findings
Usual laboratory tests revealed the raised erythrocyte
sedimentation rate and leukocytosis in more than half
patients, anemia and leukocytosis in 11 patients, leuko-
cytosis in 9, and only anemia in five. Twenty-five pa-
tients were c-ANCA positive, six patients had positive
p-ANCAs with anti MPO antibodies. One patient was
both, p- and c-ANCA positive. Negative ANCA test re-
sults were in 5 (13.5%) patients. All patients were ANA
negative. Presenting features are shown in the Table 5.
Diagnosis
Diagnosis of WG was based on the evaluation of clini-
cal manifestations and histological analysis of involved
organs. American College of Rheumatology criteria were
fulfilled in all patients. In three of 37 patients, the diag-
nosis was established on the basis of clinical manifesta-
tions and positive c-ANCA tests with blood serum titers
from 1:32 to 1:1024. Pathohistological verification was
achieved in 34 (91.9%) patients from biopsy of involved
organs (bronchi 10 cases, lung 9 cases, kidneys 8 cases,
skin 5 and oral mucosa in two cases). Positive both ANCA
test and biopsy were found in 29 (78.3%) patients while
negative ANCA test with positive biopsy was registered
in 5 (13.5%) patients.
Discussion and Conclusion
Patient's characteristics
Wegener’s granulomatosis (WG) is systemic, necroti-
zing granulomatous vasculitis primarly affecting the up-
per and lower respiratory tracts and kidneys, but it may
also involve any other organ. The onset of disease is usu-
ally between 25 and 50 years, but it can occur in child-
hood. The mean age of our patients (46.2 years) is similar
to that of other series. The sex ratio was about equal. The
course varies from acute systemic disease with lung and
renal manifestations to subacute or even indolent. There
is usually a delay in the diagnosis in patients with a mild
disease and indolent progression5 which occurred in two
of our patients. Diagnosis of Wegener’s granulomatosis
in the early stage is difficult because of the nonspecific
symptoms which mimic other infectious, granulomatous
diseases, vasculitides and neoplastic disorders. Initial
nonspecific symptoms include fever, malaise, weight loss,
arthralgia, and myalgia. These symptoms were more fre-
quent in our patients than previously reported 1,2.
Upper and lower airway manifestations
Most patients have initial upper airway symptoms,
such as nasal discharge, sinusitis, or epistaxis5,7,8. The
degree of involvement differs ranging from rhinorrhea
and nasal discomfort to nasal mucosal ulceration. Sinus-
itis is present at initial presentation in about one half to
two thirds of patients with WG7. Sinusitis can be mild or
involve the bony wall of sinuses. Radiologic imaging
studies are helpful in diagnosing Wegener’s granulo-
matosis, including sinus radiographs and CT. A compute-
rized tomography is more informative than plain radio-
graphs in cases with destructive and erosive bone chan-
ges. Otitis media is usually the result of blockage of the
Eustachian tube. Suppurative otitis, sensory neural deaf-
ness and mastoiditis can occur2,5,9. Oral lesions are rare
at initial presentation. The disease may remain localized
to the oral cavity for several weeks or months before
multi-organ involvement occurs10. This manifestation of
WG was more frequent in our patients than previously
reported1,2,15. Characteristic pathologic changes of WG
are often absent from the biopsy specimens of upper air-
ways. Upper respiratory tract involvement in our series
is lower than previously reported2,11,12,13.
Pulmonary symptoms like cough, hemoptysis and dys-
pnea were more frequent in our series than in the litera-
ture data2,11,12,14. That can be explained by the fact that
all patients were collected from the Institute for chest
diseases and TB. Lung function test were done in 64.8%
patients at initial presentation and the most common ab-
normality was restrictive pattern. Fiberoptic bronchos-
copy in most patients with WG shows nonspecific inflam-
matory lesions. Lung biopsy specimens, especially if obtai-
ned by an open-lung procedure, usually reveal necrotizing
granulomas and vasculitis11,12.
Radiographic changes in the lungs are found in 50–75%
of patients. The chest CT is more useful for further char-
acterizing the image features. It can reveal the lesions
which were not seen on the chest x-ray. Furthermore, CT
often shows previously unsuspected necrotic content in
nodules and consolidations. Most characteristic pulmo-
nary findings are opacities that vary in the character
from nodular masses to ill-defined areas of consolidation,
both of which may cavitate28–33. The nodules are roun-
ded, range from a few millimeters to several centimeters
in size, the largest being usually excavated. This finding
is highly suggestive of WG. The number of nodules is
usually less than ten but may be innumerable5,12–14. The
focal consolidations are commonly pleural based and
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TABLE 5






Elevated ESR 23 (62.1%) 126 (80%) 25 (100%)
Anemia 16 (43.2%) 115 (73%) 22 (90%)
Leukocytosis 20 (54.0%) NR 25 (100%)
Proteinuria 25 (67.5%) 28 (18%) 18 (72%)
Hematuria 25 (67.5%) 28 (18%) 18 (72%)
ANCA 32 (86.5%) 139 (88%) 17 (70%)
have a wedge shaped configuration with or without air
bronchogram. The patchy and of low density infiltrates
have also been described11,14–16. As with three of our pa-
tients, diffuse, bilateral and low density patterns may oc-
cur. Pathologic examinations of the lung in such cases re-
veal diffuse hemorrhage and capillaritis17. This is a seri-
ous manifestation of lower respiratory tract involve-
ment. In patients with pulmonary hemorrhage concur-
rent kidney failure may be present. It may results in the
erroneous diagnosis of Goodpasture disease despite the
absence of antiglomerular basementmembrane antibody17.
Some times there is a mixed pattern of nodules and con-
solidation. The present series shows difference in radio-
logical features in the lungs when compared with re-
ported series. In our study, nodules and areas of consolida-
tion were observed at the same frequency. In the studies
by Kumar5, Lee14 and Cordier15 the most common finding
of WG were nodules or masses followed by consolidation.
In all of these studies, one half to two thirds of nodules
and masses cavitated. The study by Lohrman et al.16
found the nodules in 89% patients and mixture of consol-
idation, nodules and bronchial wall thickening in about a
half of patients. The finding similar as in our study was
found by Hoffman et al. in a series of 158 patients2.
Peribronchovascular thickening also has been repor-
ted. In the study by Lee et al.14 this finding was detected
on CT in 73% of patients. Although the large airway
manifestations of Wegener’s granulomatosis are not fre-
quent at initial presentation, tracheal narrowing is not
unusual finding3. Tracheal stenosis is usually subglottic
as occurred in one patient in our series. It manifests on
CT or MRI as a mural thickening and narrowing of in-
volved part16. Laryngeal involvement has been described
in up to 30% of patients14,19. Lesions less often affect true
vocal cords and epiglottis and may be ulcerative or pro-
liferative. In one of our patient, ulceration affected true
vocal folds. In other reported studies frequency of large
airway involvement was as similar as in our study2. A va-
riety of less common intrathoracic manifestations in WG
have been reported. Pleural effusions, pneumothorax
and hydropneumothorax occur rarely and vary in seve-
rity16,20,21. Hilar and mediastinal adenopathy have been
detected in up to 2% of cases, typically with other pulmo-
nary manifestations of WG18. This finding was seen in
one of our patients.
Renal manifestations
The proportion of patients with kidney involvement
at disease presentation has varied between studies from
less than 20% to 80%. Kidney involvement in Wegener's
granulomatosis heralds a more severe outcome22. Micro-
scopic or macroscopic haematuria with proteinuria is
usually the only evidence of renal involvement22,23. It was
noted in all patients with kidney failure manifestations
in our series. The renal involvement in our study was
much higher than in other reported series. In studies by
Hoffman2 and Fauci1 renal involvement was present in
less than 20% of patients. Study by Aasarod K et al. re-
vealed in 34.3% of 108 patients a various degrees of renal
involvement at disease presentation22. Large echogenic
kidneys on ultrasound without specific Doppler abnor-
malities are the most common early finding. Although
this is a non-specific finding, it is the most common sign
of early glomerulonephritis, implying involvement of the
kidney by Wegener’s granulomatosis. Renal biopsy speci-
mens reveal changes typical of focal segmental glomeru-
lonephritis or a necrotizing proliferative glomeruloneph-
ritis with crescent formation2,22.
Other organ manifestations
Arthralgia and arthritis of small and large joints are
seen in 30–68 % of cases and may be misdiagnosed as
rheumatoid arthritis unless other features typical of WG
are present2,5,24. Our patients had non specific muscu-
loskeletal symptoms with arthralgia and myalgia. Skin is
also involved in some cases. Urticaria, palpable purpura,
papules, vesicles, erythema and petechiae are the com-
mon manifestations1,2,5,25. Skin manifestations of WG
were more common in our study than in reported se-
ries1,2,15. Patients with histologically confirmed necrotizing
vasculitis in cutaneous lesions have worse prognosis than
those with a predominant granulomatous reaction25.
Ocular abnormalities like proptosis, conjunctivitis,
episcleritis, sclerocorneal ulcerations, uveitis, retinal vas-
culitis, central retinal artery occlusion are present at the
beginning of disease in 15–30%2,12,26. Only three (8.1%) of
our patients had mild ocular symptoms with scleritis,
conjunctivits and retinal vasculitis.
Neurological conditions like mononeuritis multiplex,
peripheral neuropathy are seen in about 8% of cases at
early stage while central nervous system abnormalities
(cranial nerve palsies, cerebral infarcts, transverse my-
elitis and seizurs) occurred rarely1,2,27,28. Only two of our
patients had neurological disorders with mononeuritis
multiplex.
Biochemical analyses
Usual laboratory tests are nonspecific because they
only point to an inflammatory syndrome with a rised
eritrocyte sedimentation rate, leukocytosis and anemia2,15.
The association between Wegener’s granulomatosis and
the presence of antineutrophil cytoplasmic antibodies
(ANCA) in the blood has been reported by numerous
investigators4,29. Even though a positive c-ANCA test is
of great value in confirming a diagnosis of WG, it is still
negative in some cases, particularly in those with local-
ized form of the disease2,30. It was found negative in five
(13.5%) patients in our series (four with limited and one
with generalized form of WG).
The results of our study show that clinical symptoms
and radiologic features of lung diseases at initial presen-
tation of WG are slightly different from the reported
series2,5,11,12,22,13–16. It could be explained by relatively
small number of patients and by the fact that all patients
were recruited from a referral center.
Today WG is more frequently diagnosed in Serbia at
an early stage of disease because of awareness and avail-
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ability of diagnostic techniques. In patients who have
non-resolving chest x-ray opacities a thorough clinical
examination and all relevant investigations should be
performed. Upper and lower respiratory tract symptoms
along with active urine sediment should raise the clini-
cian’s awareness of Wegener’s granulomatosis.
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WEGENEROVA GRANULOMATOZA: KLINI^KE I RADIOLO[KE ZNA^AJKE NA PO^ETNOJ
PREZENTACIJI
S A @ E T A K
Dijagnoza Wegenerove granulomatoze u ranoj fazi je te{ka zbog nespecifi~nih simptoma koji imitiraju druge bolesti.
Cilj ovog rada je opisati klini~ke i radiolo{ke zna~ajke Wegenerove granulomatoze (WG) u srpskoj populaciji na po~etnoj
prezentaciji. Proveden je retrospektivni pregled podataka za 37 pacijenata. U svih ovih pacijenata je je dijagnosticirana
WG i oni su bili na Institutu za plu}ne bolesti u Beogradu tijekom razdoblja od 15 godina. Bilo je 20 mu{karaca i 17
`ena, u dobi od 18 do 73 godina (prosje~ne dobi 46,2 godina). Prosje~no razdoblje od po~etka prvih simptoma do dijag-
noze WG je 4,59 ± 6,15 mjeseci. Kriteriji Ameri~ke Visoke {kole za reumatologiju su ispunjeni u svih bolesnika. Dva-
deset i pet od trideset i sedam bolesnika imalo je sustavan, generalizirani oblik WG, dok je njih 12 imalo ograni~enu
zahva}enost gornjeg i donjeg di{nog sustava. U~estalost zahva}enosti razli~itih sustava je: gornjih di{nih putova 64,8%,
donjih di{nih putova 100%, bubrega 67,5%, mi{i}noskeletnog sustava 40,5%, ko`e 27,2%, o~i 8,1%, a `iv~anog sustava u
dva bolesnika. ANCA (Antineutrofilna citoplazmatska antitijela) test je bio pozitivan u 32 (86,5%) bolesnika, a ne-
gativan u 5 (13,5%). Svi bolesnici su bili ANA negativni. Histolo{ki dokaz granulomatozna vaskulitisa ostvaren je u 34
(91,9%), dok se u tri bolesnika dijagnoza temelji na klini~kimmanifestacijama i pozitivnom c-ANCA ispitivanju. Postoje
manje razlike u na{im podacima, u usporedbi s onima u literaturi.
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